Stanley Druckenmiller acquired 907 Thousand Recursion Pharmaceuticals shares worth $6.66 Million. That's 0.18% of their equity portfolio (42nd largest holding). Stanley Druckenmiller started to build up the position in Recursion Pharmaceuticals in Q3 2021 and continued to invest until Q3 2022. Since then they sold 479 Thousand shares. The investor's estimated purchase price is $12.3 Million, resulting in a loss of 46%.